Literature DB >> 16378961

Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression.

Michael Guarnieri1, Kyun-Hwan Kim, Genie Bang, Jisu Li, Yonghong Zhou, Xiaoli Tang, Jack Wands, Shuping Tong.   

Abstract

The pregenomic RNA directs replication of the hepatitis B virus (HBV) genome by serving both as the messenger for core protein and polymerase and as the genome precursor following its packaging into the core particle. RNA packaging is mediated by a stem-loop structure present at its 5' end designated the epsilon signal, which includes the core gene initiator AUG. The precore RNA has a slightly extended 5' end to cover the entire precore region and, consequently, directs the translation of a precore/core protein, which is secreted as e antigen (HBeAg) following removal of precore-derived signal peptide and the carboxyl terminus. A naturally occurring G1862T mutation upstream of the core AUG affects the bulge of the epsilon signal and generates a "forbidden" residue at the -3 position of the signal peptide cleavage site. Transfection of this and other mutants into human hepatoma cells failed to prove their inhibition of HBeAg secretion but rather revealed great impairment of genome replication. This replication defect was associated with reduced expression of core protein and could be overcome by a G1899A covariation, or by nonsense or frameshift mutation in the precore region. All these mutations antagonized the G1862T mutation on core protein expression. Cotransfection of the G1862T mutant with a replication-deficient HBV genome that provides core protein in trans also restored genome replication. Consistent with our findings in cell culture, HBV genotype A found in African/Asian patients has T1862 and is associated with much lower viremia titers than the European subgroup of genotype A.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378961      PMCID: PMC1346833          DOI: 10.1128/JVI.80.2.587-595.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  A pregenomic RNA sequence adjacent to DR1 and complementary to epsilon influences hepatitis B virus replication efficiency.

Authors:  Hong Tang; Alan McLachlan
Journal:  Virology       Date:  2002-11-10       Impact factor: 3.616

2.  Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion.

Authors:  Genie Bang; Kyun-Hwan Kim; Michael Guarnieri; Fabien Zoulim; Shigenobu Kawai; Jisu Li; Jack Wands; Shuping Tong
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

3.  Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production.

Authors:  Sang Hoon Ahn; Anna Kramvis; Shigenobu Kawai; Hans Christian Spangenberg; Jisu Li; Gerald Kimbi; Michael Kew; Jack Wands; Shuping Tong
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

4.  Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting.

Authors:  Nandini Sen; Feng Cao; John E Tavis
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D.

Authors:  Yasuhito Tanaka; Izumi Hasegawa; Takanobu Kato; Etsuro Orito; Noboru Hirashima; Subrat K Acharya; Robert G Gish; Anna Kramvis; Michael C Kew; Namiko Yoshihara; Santosh Man Shrestha; Mobin Khan; Yuzo Miyakawa; Masashi Mizokami
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

6.  Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Authors:  Sameer Parekh; Fabien Zoulim; Sang Hoon Ahn; Adrienne Tsai; Jisu Li; Shigenobu Kawai; Nasser Khan; Christian Trépo; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene.

Authors:  Nasser Khan; Michael Guarnieri; Sang Hoon Ahn; Jisu Li; Yonghong Zhou; Genie Bang; Kyun-Hwan Kim; Jack R Wands; Shuping Tong
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Detection and significance of a G1862T variant of hepatitis B virus in Chinese patients with fulminant hepatitis.

Authors:  Jinlin Hou; Yulong Lin; Jenny Waters; Zhanhui Wang; Jia Min; Huiyu Liao; Jiaji Jiang; Jinjun Chen; Kangxian Luo; Peter Karayiannis
Journal:  J Gen Virol       Date:  2002-09       Impact factor: 3.891

9.  Influences of mRNA secondary structure on initiation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A.

Authors:  Fuminaka Sugauchi; Hiromitsu Kumada; Subrat A Acharya; Santosh Man Shrestha; Maria Teresita A Gamutan; Mobin Khan; Robert G Gish; Yasuhito Tanaka; Takanobu Kato; Etsuro Orito; Ryuzo Ueda; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Gen Virol       Date:  2004-04       Impact factor: 3.891

View more
  24 in total

1.  Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates.

Authors:  Yanli Qin; Jiming Zhang; Tamako Garcia; Kiyoaki Ito; Danielle Gutelius; Jisu Li; Jack Wands; Shuping Tong
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

Review 2.  Hepatitis B virus replication.

Authors:  Juergen Beck; Michael Nassal
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Critical role of the 36-nucleotide insertion in hepatitis B virus genotype G in core protein expression, genome replication, and virion secretion.

Authors:  Ke Li; Fabien Zoulim; Christian Pichoud; Karen Kwei; Stéphanie Villet; Jack Wands; Jisu Li; Shuping Tong
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

4.  Adaptive mutations in the signal peptide of the type 1 fimbrial adhesin of uropathogenic Escherichia coli.

Authors:  Leah S Ronald; Olga Yakovenko; Nina Yazvenko; Sujay Chattopadhyay; Pavel Aprikian; Wendy E Thomas; Evgeni V Sokurenko
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-29       Impact factor: 11.205

Review 5.  Precore/core region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Seung Yeon Do; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

6.  Characterization of occult hepatitis B virus infection from blood donors in China.

Authors:  Xin Zheng; Xianlin Ye; Ling Zhang; Wenjing Wang; Lifang Shuai; Anqi Wang; Jinfeng Zeng; Daniel Candotti; Jean-Pierre Allain; Chengyao Li
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

7.  Functional characterization of hepatitis B virus core promoter mutants revealed transcriptional interference among co-terminal viral mRNAs.

Authors:  Chaoyang Chen; Haodi Jia; Fei Zhang; Yanli Qin; Li Zong; Quan Yuan; Yongxiang Wang; Ningshao Xia; Jisu Li; Yumei Wen; Shuping Tong
Journal:  J Gen Virol       Date:  2016-08-23       Impact factor: 3.891

8.  Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.

Authors:  Jean-Pierre Vartanian; Michel Henry; Agnès Marchio; Rodolphe Suspène; Marie-Ming Aynaud; Denise Guétard; Minerva Cervantes-Gonzalez; Carlo Battiston; Vincenzo Mazzaferro; Pascal Pineau; Anne Dejean; Simon Wain-Hobson
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

9.  Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion.

Authors:  Tamako Garcia; Jisu Li; Camille Sureau; Kiyoaki Ito; Yanli Qin; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations.

Authors:  Adrienne Tsai; Shigenobu Kawai; Karen Kwei; Dina Gewaily; Alexander Hutter; David R Tong; Jisu Li; Jack R Wands; Shuping Tong
Journal:  Virology       Date:  2009-03-26       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.